With Christopher Mackey, Emily Melvin, Vera Nackovic, Scott Perlman, John Roberti, Arthur Walker, Jr.
The developments include a proposed modification to the HSR Form that would impact reporting requirements, AIAs First-Inventor-to-File provisions, Federal Circuit cases to watch, Reverse-Payment legislation, proposed State legislation concerning the substitution of biosimilar products, the US Federal Excise Tax on medical devices sales and the FDAs draft guidance for the evaluation and labeling of abuse-deterrent opioids.